Epidermal growth factor (EGF), also referred to as epithelial growth factor, is produced in various tissues and exerts stimulatory effects on cell growth, proliferation and survival. Because mutations of EGF receptor (EGFR) are observed in many human cancers, this receptor has been studied mainly as a target for anticancer therapy. Indeed, several EGFR inhibitors are currently available for the treatment of tumors. However, studies performed during the last decade strongly suggest that abnormal EGFR-mediated signaling plays an important role in cardiovascular pathology. EGFR is abundantly expressed